Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Solid Biosciences Inc SLDB

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3... see more

Recent & Breaking News (NDAQ:SLDB)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solid Biosciences Inc. - SLDB

GlobeNewswire November 12, 2019

Solid Biosciences Provides SGT-001 Program Update

GlobeNewswire November 12, 2019

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Solid Biosciences Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire October 16, 2019

Solid Biosciences to Participate in the Chardan 3rd Annual Genetic Medicines Conference

GlobeNewswire October 2, 2019

Solid Biosciences Announces Publication Highlighting the Important Role of the nNOS Domain in Microdystrophin Function and its Potential Utility in DMD Gene Therapy in the Journal Neuromuscular Disorders

GlobeNewswire September 5, 2019

Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire August 14, 2019

Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors

GlobeNewswire July 26, 2019

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Solid Biosciences Inc. (SLDB)

Press Releases May 16, 2019

Solid Biosciences Reports First Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire May 13, 2019

Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

GlobeNewswire March 13, 2019

Lifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.

PR Newswire February 20, 2019

SHAREHOLDER ALERT: Investigation of Solid Biosciences Inc. Announced by Holzer & Holzer, LLC

Business Wire February 7, 2019

Solid Biosciences Announces Preliminary SGT-001 Data and Intention to Dose Escalate in IGNITE DMD Clinical Trial for Duchenne Muscular Dystrophy

GlobeNewswire February 7, 2019

Solid Biosciences to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire January 2, 2019

Research Report Identifies Chicken Soup for the Soul Entertainment, Allied Motion Technologies, Bandwidth, Solid Biosciences, Avenue Therapeutics, and BeyondSpring with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire November 21, 2018

Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business Update

GlobeNewswire November 13, 2018

Solid Biosciences to Present at the Credit Suisse Healthcare Conference

GlobeNewswire November 9, 2018

Solid Biosciences to Present at the Chardan Genetic Medicines Conference

GlobeNewswire October 5, 2018

Solid Biosciences to Present at the Cell & Gene Meeting on the Mesa

GlobeNewswire October 1, 2018

Solid Biosciences Welcomes Sukumar Nagendran, M.D., To Its Board Of Directors

GlobeNewswire September 13, 2018